{"version":"1.0","provider_name":"Vitro master diagn\u00f3stica","provider_url":"https:\/\/vitro.bio\/en\/","title":"Vitro Appoints Biocare Medical as Exclusive Distributor in the U.S. for NeoPATH Pro Instrument Launch at USCAP 2025 - Vitro master diagn\u00f3stica","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"PCNa3qO85j\"><a href=\"https:\/\/vitro.bio\/en\/vitro-appoints-biocare-medical-as-exclusive-distributor-in-the-usa\/\">Vitro Appoints Biocare Medical as Exclusive Distributor in the U.S. for NeoPATH Pro Instrument Launch at USCAP 2025<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/vitro.bio\/en\/vitro-appoints-biocare-medical-as-exclusive-distributor-in-the-usa\/embed\/#?secret=PCNa3qO85j\" width=\"600\" height=\"338\" title=\"&#8220;Vitro Appoints Biocare Medical as Exclusive Distributor in the U.S. for NeoPATH Pro Instrument Launch at USCAP 2025&#8221; &#8212; Vitro master diagn\u00f3stica\" data-secret=\"PCNa3qO85j\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/vitro.bio\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/vitro.bio\/wp-content\/uploads\/2025\/03\/acuerdo-vitro-biocare-medical.jpg","thumbnail_width":1500,"thumbnail_height":725,"description":"[San Francisco, California], [March 12, 2025] Vitro, a global developer, manufacturer and marketer of integral diagnostics solutions and data integration in Cancer Diagnostics, today announced that it has appointed Biocare Medical, a global leader in advanced staining solutions and reagents, as the exclusive distributor for its new NeoPATH Pro instrument in the United States. The..."}